<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(2)</volume><submitter>Xia T</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>Several published literatures investigated the relation between a polymorphism (Leul25Val) in platelet endothelial cell adhesion molecule-1 (PECAM-1) gene and risk of coronary heart disease (CHD) and did not reach the same conclusion. To shed light on these inconclusive findings, we performed a meta-analysis of studies relating the PECAM-1 genetic polymorphism (Leul25Val) to the risk of CHD.&lt;h4>Methods&lt;/h4>We identified literatures by searching PubMed, EMBASE, Chinese National Knowledge Infrastructure databases (CNKI) and Wanfang database in China. Data from eligible studies were extracted for meta-analysis. CHD risk associated with PECAM-1 genetic polymorphism (Leul25Val) was estimated by pooled odds ratios (ORs) and 95% confidence intervals (95% CIs). The software Revie</pubmed_abstract><journal>International journal of clinical and experimental medicine</journal><pagination>2219-25</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4402801</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Association of Leu125Val polymorphisms in the PECAM-1 gene with the risk of coronary heartdisease: a meta-analysis.</pubmed_title><pmcid>PMC4402801</pmcid><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Li G</pubmed_authors><pubmed_authors>Jin X</pubmed_authors><pubmed_authors>Du CJ</pubmed_authors><pubmed_authors>Kong XQ</pubmed_authors><pubmed_authors>Xia T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association of Leu125Val polymorphisms in the PECAM-1 gene with the risk of coronary heartdisease: a meta-analysis.</name><description>&lt;h4>Objective&lt;/h4>Several published literatures investigated the relation between a polymorphism (Leul25Val) in platelet endothelial cell adhesion molecule-1 (PECAM-1) gene and risk of coronary heart disease (CHD) and did not reach the same conclusion. To shed light on these inconclusive findings, we performed a meta-analysis of studies relating the PECAM-1 genetic polymorphism (Leul25Val) to the risk of CHD.&lt;h4>Methods&lt;/h4>We identified literatures by searching PubMed, EMBASE, Chinese National Knowledge Infrastructure databases (CNKI) and Wanfang database in China. Data from eligible studies were extracted for meta-analysis. CHD risk associated with PECAM-1 genetic polymorphism (Leul25Val) was estimated by pooled odds ratios (ORs) and 95% confidence intervals (95% CIs). The software Revie</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015</publication><modification>2025-04-20T01:14:33.276Z</modification><creation>2024-11-08T09:15:45.927Z</creation></dates><accession>S-EPMC4402801</accession><cross_references><pubmed>25932154</pubmed></cross_references></HashMap>